Open an account

BIO-Key International

BKYI · NASDAQ

$2.30+$0.03 (+1.32%)TodayMarket closed ·
Prev close $2.27

About BKYI

BIO-key International, Inc. engages in the provision of an identity and access management platform. The company is headquartered in Holmdel, New Jersey and currently employs 41 full-time employees. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.

Employees
41
Headquarters
Holmdel, New Jersey
Listed
Apr 17, 1997
Sector
Information Technology
Industry
Software
Website
bio-key.com

BKYI key statistics

Market cap
4.68M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
13.03M
Volume
135.15K
Open price
$2.28
High today
$2.69
Low today
$2.27
52 Week high
$19.70
52 Week low
$1.55

BIO-Key International (BKYI) at a glance

BIO-Key International (BKYI) last traded at $2.30, with a market cap of 4.68M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $2.27 and $2.69. The current price is 1.3% above the day's low and 14.5% below its high.

Volume so far is 135.15K shares, below the average of 13.03M shares a day.

Over the past year BIO-Key International has ranged from $1.55 to $19.70, and now sits 4% of the way up that range.

BIO-Key International met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported -$0.56 per share against an estimate of -$0.816.

BKYI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 47.0% on average.

  1. Q2 FY24: reported -$10.00 per share against an estimate of -$5.51
  2. Q3 FY24: reported -$3.90 per share against an estimate of -$5.92
  3. Q4 FY24: reported -$5.30 per share against an estimate of -$3.57
  4. Q2 FY25: reported -$2.00 per share against an estimate of -$1.53
  5. Q3 FY25: reported -$1.50 per share against an estimate of -$1.22
  6. Q4 FY25: reported -$1.90 per share against an estimate of -$0.714
  7. Q1 FY26: reported -$0.15 per share against an estimate of -$0.612
  8. Q2 FY26: reported -$0.56 per share against an estimate of -$0.816

BKYI news

  • 12 Information Technology Stocks Moving In Tuesday's After-Market Session

  • 12 Information Technology Stocks Moving In Wednesday's Pre-Market Session

  • Avi Kapoor

    Crude Oil Edges Higher; Citigroup Earnings Top Views

  • Avi Kapoor

    Dow Rises Over 100 Points; Goldman Sachs Posts Upbeat Earnings

  • Akanksha Bakshi

    Why Is BIO-key International Stock Surging Tuesday?

  • Avi Kapoor

    Crude Oil Down 1%; US Job Openings Fall In August

  • Avi Kapoor

    Dow Tumbles 100 Points; Carnival Posts Upbeat Q3 Earnings

  • Tanya Rawat

    BIO-key (BKYI) Shares Fall 13% After Hours: Here's What Is Going On

Similar companies

Companies in the same industry as BIO-Key International

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.